SMTI Form 3: Director Ashley M. Mackey Discloses 2,412 Shares
Rhea-AI Filing Summary
Sanara MedTech Inc. (SMTI) Form 3 shows Ashley M. Mackey reported beneficial ownership of 2,412 shares of the issuer's common stock. The report cites an event date of 08/29/2025 and the form is signed on 09/04/2025. The filing identifies the reporting person as a Director and indicates Controller in the relationship field. No derivative securities or additional holdings are reported.
Positive
- Timely initial disclosure filed for an officer/director/controller, meeting Section 16(a) reporting requirements
- No derivative positions reported, simplifying future monitoring of potential exercises or conversions
Negative
- None.
Insights
TL;DR: Routine initial Section 16 filing reporting direct ownership of 2,412 common shares.
This Form 3 appears to be a standard initial disclosure under Section 16(a) documenting Ashley M. Mackey's direct beneficial ownership of 2,412 shares of Sanara MedTech Inc. The filing lists the relevant event date and contains no derivative positions, amendments, or additional material disclosures. For compliance purposes, the form fulfills the basic requirement to report an officer/director/controller's initial holdings.
TL;DR: Initial ownership disclosure only; nothing material to company valuation or control.
The disclosure identifies the reporting person as a director and lists "Controller" in the relationship field while reporting only direct common stock ownership of 2,412 shares. There are no option grants, warrants, convertible securities, or indirect holdings noted. This is a routine governance disclosure that does not indicate changes in control or material transactions.